Effects of Social Media Use on Young Adults' E-Cigarette Use

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are: - Does reducing social media use change young adults' e-cigarette use? - Does reducing social media use change things such as young adults' mental health and what they see on social media? Participants will complete surveys and submit screenshots showing how much time they spend on social media. Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.

Clinical Trial Description

The overall goals of this project are to understand how young adults' social media use affects their nicotine vaping and to identify intervention targets that mitigate social media's impact on vaping. Prevalence of vaping and social media use among young adults have increased in tandem. Exposure to vaping-related social media content is common and is associated with vaping. Intense social media use appears to contribute to young adults' increased mental health symptoms, which are linked to tobacco product use. This project aims to contribute to scientific understanding of the causal links between social media use and vaping in young adulthood. Young adults with past-month vaping will report time spent on social media, vaping-related social media content exposure, social comparison on social media, mental health, and vaping behavior. After a 1-month baseline measurement period, they will be randomized to reduce their social media use (incentivized) or use social media as usual for a 3-month experimental period. Longitudinal within- and between-subjects analyses will test relationships between time spent on social media, risk factors for vaping, and vaping behavior. Specific research aims are to: (1) investigate the relationships between a reduction in social media use and: a) vaping content exposure, b) social comparison, and c) mental health, and (2) examine whether reducing social media use reduces past-month vaping days, vaping episodes per vaping day, and puffs per vaping episode. ;

Study Design

Related Conditions & MeSH terms

Electronic Cigarette Use

Clinical Trial Details

NCT number	NCT06142877
Study type	Interventional
Source	University of Oklahoma
Contact	Erin A Vogel, PhD
Phone	405-271-8001
Email	erin-vogel@ouhsc.edu
Status	Recruiting
Phase	N/A
Start date	December 4, 2023
Completion date	April 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04123041` - Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems	N/A
Completed	`NCT04107779` - Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS	N/A
Completed	`NCT04620616` - Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by ENDS Consumers	N/A
Recruiting	`NCT05306158` - Dual Use Approach Bias Training for Nicotine Addiction	N/A
Completed	`NCT04143256` - Evaluating Selected Constituents in the Exhaled Breath Samples	N/A
Completed	`NCT04088175` - Study to Characterize Puffing Topography With Use of JUUL Electronic Nicotine Delivery Systems (ENDS) in Adult, Closed-System ENDS Consumers	N/A
Completed	`NCT04708106` - Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System	N/A
Recruiting	`NCT06291597` - Vaping Adverse Lung and Heart Events Cohort
Completed	`NCT05134415` - Use Behavior, Nicotine Uptake, and Subjective Effects Comparison of Tobacco and Menthol e-Liquids by ENDS Consumers	N/A
Completed	`NCT04640285` - Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by Smokers	N/A
Recruiting	`NCT05316727` - Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury
Completed	`NCT04192032` - Assessing the Effect of Flavor on ENDS Users' Experiences and Exposures	N/A
Recruiting	`NCT05278065` - E-cigarettes for Harm Reduction in Adults With Asthma	N/A
Recruiting	`NCT05206435` - Methadone-Maintained Smokers Switching to E-Cigarettes	Phase 4
Completed	`NCT04316234` - Acute Health Effects of Passive Vape Among COPD Patients	N/A
Completed	`NCT04450537` - PACE Vape Messaging Study	N/A
Recruiting	`NCT05338801` - Effect of Menthol on ENDS Users' Addiction and Exposure	N/A
Recruiting	`NCT05423340` - Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems	N/A
Terminated	`NCT03974152` - Effects of Nicotine Salt Aerosol on Cigarette Smokers	N/A
Not yet recruiting	`NCT06063421` - Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.